Coeptis Therapeutics Holdings (Coeptis Therapeutics Holdings) Pre-Tax Income : $-16.31 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Coeptis Therapeutics Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Coeptis Therapeutics Holdings's pretax income for the three months ended in Mar. 2024 was $-3.00 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-16.31 Mil. Coeptis Therapeutics Holdings's pretax margin was %.

During the past 4 years, Coeptis Therapeutics Holdings's highest Pretax Margin was -17932.00%. The lowest was -29535.48%. And the median was -23733.74%.

Coeptis Therapeutics Holdings Pre-Tax Income Historical Data

The historical data trend for Coeptis Therapeutics Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coeptis Therapeutics Holdings Pre-Tax Income Chart

Coeptis Therapeutics Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

-9.16

-13.45

-37.57

-21.27

Coeptis Therapeutics Holdings Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial									-7.96	-3.20	-6.35	-3.76	-3.00

Competitive Comparison of Coeptis Therapeutics Holdings's Pre-Tax Income

For the Biotechnology subindustry, Coeptis Therapeutics Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coeptis Therapeutics Holdings's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coeptis Therapeutics Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Coeptis Therapeutics Holdings's Pre-Tax Income falls into.

Coeptis Therapeutics Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Coeptis Therapeutics Holdings's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-21.491	+	0.332	+	-0.108	+	0	+	0
	=	-21.27

Coeptis Therapeutics Holdings's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.922	+	0.122	+	-0.201	+	0	+	4.4408920985006E-16
	=	-3.00

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.31 Mil.

Coeptis Therapeutics Holdings (NAS:COEP) Pre-Tax Income Explanation

Coeptis Therapeutics Holdings's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-3.001	/	0
	=	%

During the past 4 years, Coeptis Therapeutics Holdings's highest Pretax Margin was -17932.00%. The lowest was -29535.48%. And the median was -23733.74%.

Coeptis Therapeutics Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Coeptis Therapeutics Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Coeptis Therapeutics Holdings (Coeptis Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coeptis Therapeutics Holdings Inc (NAS:COEP) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

105 Bradford Road, Suite 420, Wexford, PA, USA, 15090

Website

https://www.coeptistx.com

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio comprises multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Executives

Tara Desilva	director	105 BRADFORD RD., SUITE 420, WEXFORD PA 15090
David Mehalick	director, 10 percent owner, officer: CEO and President	5000 TRESSDALE DRIVE, GIBSONIA PA 15044
Christopher P. Cochran	director	105 BRADFORD RD., SUITE 420, WEXFORD PA 15090
Gene Salkind	director	1165 WRACK ROAD, MEADOWBROOK PA 19046
Daniel Alexander Yerace	director, officer: VP of Operations	402 SCHOMBURG COURT, CRANBERRY TOWNSHIP PA 16066
Chris Calise	director, 10 percent owner, officer: Chief Financial Officer	801 S. POINTE DRIVE SUITE TH-1, MIAMI BEACH FL 33139
Philippe Deschamps	director	105 BRADFORD RD, SUITE 420, WEXFORD PA 15090
Christine Elise Sheehy	officer: CFO and Secretary	206 TAMARACK DRIVE, MARS PA 16046
Harraden Circle Investments, Llc	10 percent owner	299 PARK AVE, 21ST FLOOR, NEW YORK NY 10171
Harraden Circle Investors Gp, Lp	10 percent owner	299 PARK AVE., 21ST FLOOR, NEW YORK NY 10171
Harraden Circle Investors Gp, Llc	10 percent owner	299 PARK AVE., 21ST FLOOR, NEW YORK NY 10171
Fortmiller Frederick Vincent Jr.	10 percent owner	151 LULL ROAD, NEW BOSTON NH 03070
Harraden Circle Investors, Lp	10 percent owner	299 PARK AVENUE, 21ST FLOOR, NEW YORK NY 10171
Plc Barclays	10 percent owner	1 CHURCHILL PLACE, CANARY WHARF, LONDON X0 E14 5HP
Paul J Glazer	10 percent owner	250 WEST 55TH ST, SUITE 30A, NEW YORK NY 10019